Suppr超能文献

HA-Mg 青光眼引流盘在前房植入兔眼的眼压控制效果及安全性。

Intraocular pressure control efficacy and safety of HA-Mg glaucoma drainage plate implantation in the anterior chamber of rabbit eyes.

机构信息

Department of Ophthalmology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, China.

Department of Ophthalmology, Beibei Hospital of Chongqing Medical University, Chongqing, 400700, China.

出版信息

J Mater Sci Mater Med. 2024 Jun 25;35(1):37. doi: 10.1007/s10856-024-06806-x.

Abstract

The current clinical application of glaucoma drainage devices is made of non-degradable materials. These non-degradable drainage devices often trigger inflammatory responses and scar proliferation, possibly leading to surgical failure. We developed a biodegradable material hydroxyapatite-coated magnesium (HA-Mg) as a glaucoma drainage device. Twelve New Zealand white rabbits were randomly assigned to three groups: HA-Mg drainage plate group (6 right eyes), trabeculectomy group (6 right eyes), and control group (12 left eyes). Results showed that all HA-Mg drainage plates were completely degraded ~4 months postoperatively. At the 5th month postoperatively, there was no statistical difference in the corneal endothelium density between the HA-Mg drainage plate group and the control group (p = 0.857). The intraocular pressure (IOP) level in the HA-Mg drainage plate implantation group was lower than in the other two groups. The trypan blue dye still drained from the anterior chamber to the subconjunctiva 5 months after HA-Mg drainage plate implantation. HE staining revealed the scleral linear aqueous humor drainage channel and anterior synechia were observed after drainage plate completely degraded, with no obvious infiltration with the inflammatory cells. This study showed the safety and efficacy of HA-Mg glaucoma drainage plate in controlling IOP after implantation into the anterior chamber of rabbit eyes.

摘要

当前青光眼引流装置的临床应用采用的是不可降解材料。这些不可降解的引流装置通常会引发炎症反应和瘢痕增殖,可能导致手术失败。我们开发了一种可生物降解材料——羟基磷灰石涂层镁(HA-Mg)作为青光眼引流装置。将 12 只新西兰白兔随机分为三组:HA-Mg 引流板组(6 只右眼)、小梁切除术组(6 只右眼)和对照组(12 只左眼)。结果表明,所有 HA-Mg 引流板在术后约 4 个月完全降解。术后 5 个月,HA-Mg 引流板组与对照组角膜内皮细胞密度无统计学差异(p=0.857)。HA-Mg 引流板植入组的眼内压(IOP)水平低于其他两组。在 HA-Mg 引流板植入 5 个月后,仍有台盼蓝染料从前房引流到结膜下。HE 染色显示巩膜线性房水引流通道,引流板完全降解后观察到前粘连,无明显炎症细胞浸润。本研究表明,HA-Mg 青光眼引流板在植入兔眼前房后控制 IOP 是安全有效的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/669a/11199312/f61d2d48175f/10856_2024_6806_Figa_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验